quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:01:44·1165d
SECFiling
Sio Gene Therapies Inc. logo

Sio Gene Therapies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

SIOX· Sio Gene Therapies Inc.
Health Care
Original source

Companies

  • SIOX
    Sio Gene Therapies Inc.
    Health Care

Recent analyst ratings

  • Feb 1UpdateHC Wainwright & Co.$7.00
  • Feb 1UpdateSVB Leerink$1.00
  • Oct 21UpdateHC Wainwright & Co.$10.00
  • Aug 12UpdateSVB Leerink$6.00
  • Jul 12UpdateChardan Capital Markets$12.50

Related

  • PR812d
    Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share
  • SEC1094d
    SEC Form 15-12G filed by Sio Gene Therapies Inc.
  • SEC1095d
    SEC Form EFFECT filed by Sio Gene Therapies Inc.
  • SEC1102d
    SEC Form POS AM filed by Sio Gene Therapies Inc.
  • SEC1102d
    SEC Form S-8 POS filed by Sio Gene Therapies Inc.
  • SEC1108d
    SEC Form 25-NSE filed by Sio Gene Therapies Inc.
  • SEC1113d
    SEC Form 25 filed by Sio Gene Therapies Inc.
  • SEC1113d
    Sio Gene Therapies Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022